CARY, N.C.--(EON: Enhanced Online News)--Biologics, Inc. is excited to announce a new strategic partnership with Academic and Community Cancer Research United (ACCRU) providing its comprehensive Clinical Research Services for the ACCRU Research Coordinating Center. Biologics will manage all logistics and distribution for ACCRU, which includes customized accountability reporting to support ACCRU’s protocol specifications that will ensure the integrity of each trial.
“We believe this partnership will enable ACCRU to provide direct drug shipment services to select ACCRU studies, thereby better serving our members.”
ACCRU is a network of more than 75 academic and community-based cancer treatment clinics and hospitals in the United States and Canada.
“We are pleased to partner with Biologics,” said Axel Grothey, M.D., ACCRU chair and an oncologist at Mayo Clinic in Rochester, Minn. “We believe this partnership will enable ACCRU to provide direct drug shipment services to select ACCRU studies, thereby better serving our members.”
Biologics’ Clinical Research Services team currently supports over 200 protocols across 55 active clinical trials – focusing primarily in oncology. Licensed to dispense in all 50 states, service components include drug and supply procurement, patient kit design, inventory management and customized reporting.
“Biologics strives to provide the highest quality care to cancer patients, and we are thrilled for the opportunity to support ACCRU’s mission in developing and conducting high quality cancer research,” said Dan Duffy, Chief Business Development Officer at Biologics.
About Biologics, Inc.
Biologics, Inc. is an oncology services company that empowers healthcare providers, payors and biopharma to optimize cancer care for the best possible outcomes – clinical, financial and emotional. Unifying fragmented healthcare services, Biologics brings efficiency and humanity to oncology care management by focusing on the patient’s best interest as the surest path to managing cost and risk. Biologics is at the center of a rapidly changing oncology environment and supports patients across all treatment modalities, while providing clinical outcomes and informatics reporting that allow for informed decision making. Since it was founded in 1994, Biologics has been dedicated to improving the lives of those fighting cancer. Privately held, Biologics maintains headquarters and operations in Cary, North Carolina.